Log in

NYSE:VARVarian Medical Systems Stock Price, Forecast & News

$132.37
+5.27 (+4.15 %)
(As of 06/5/2020 04:00 PM ET)
Add
Compare
Today's Range
$129.17
Now: $132.37
$133.59
50-Day Range
$104.10
MA: $115.67
$128.85
52-Week Range
$89.62
Now: $132.37
$150.06
Volume544,657 shs
Average Volume817,904 shs
Market Capitalization$12.02 billion
P/E Ratio48.67
Dividend YieldN/A
Beta1.08
Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Proton Solutions. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as related quality assurance equipment. Its products include linear accelerators, brachytherapy after loaders, treatment accessories, and quality assurance software; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, medical oncology practices, radiotherapy centers, and cancer care clinics. The Proton Solutions segment designs, develops, manufactures, sells, and services products and systems for delivering proton therapy for the treatment of cancer. Varian Medical Systems, Inc. has a strategic partnership with Siemens AG to co-develop new imaging and treatment solutions; and a strategic cooperation framework agreement with Shandong Cancer Hospital for proton therapy clinical application and research in China. The company was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. Varian Medical Systems, Inc. was founded in 1948 and is headquartered in Palo Alto, California.
Read More
Varian Medical Systems logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.2Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.55 out of 5 stars


Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP92220P10
Phone650-493-4000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.23 billion
Cash Flow$5.85 per share
Book Value$19.52 per share

Profitability

Net Income$291.90 million

Miscellaneous

Employees10,062
Market Cap$12.02 billion
Next Earnings Date7/22/2020 (Estimated)
OptionableOptionable

Receive VAR News and Ratings via Email

Sign-up to receive the latest news and ratings for VAR and its competitors with MarketBeat's FREE daily newsletter.

Varian Medical Systems (NYSE:VAR) Frequently Asked Questions

How has Varian Medical Systems' stock been impacted by COVID-19 (Coronavirus)?

Varian Medical Systems' stock was trading at $113.04 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, VAR shares have increased by 17.1% and is now trading at $132.37. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Varian Medical Systems?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Varian Medical Systems in the last year. There are currently 2 sell ratings, 1 hold rating and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Varian Medical Systems.

When is Varian Medical Systems' next earnings date?

Varian Medical Systems is scheduled to release its next quarterly earnings announcement on Wednesday, July 22nd 2020. View our earnings forecast for Varian Medical Systems.

How were Varian Medical Systems' earnings last quarter?

Varian Medical Systems, Inc. (NYSE:VAR) announced its quarterly earnings data on Monday, May, 4th. The medical equipment provider reported $0.85 earnings per share for the quarter, meeting the Zacks' consensus estimate of $0.85. The medical equipment provider earned $794.50 million during the quarter, compared to the consensus estimate of $769.99 million. Varian Medical Systems had a return on equity of 22.93% and a net margin of 7.51%. The company's quarterly revenue was up 1.9% compared to the same quarter last year. During the same period in the prior year, the business earned $1.05 EPS. View Varian Medical Systems' earnings history.

What guidance has Varian Medical Systems issued on next quarter's earnings?

Varian Medical Systems issued an update on its second quarter 2020 Pre-Market earnings guidance on Monday, March, 9th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $800-825 million, compared to the consensus revenue estimate of $871.75 million.

What price target have analysts set for VAR?

8 brokerages have issued 1 year price targets for Varian Medical Systems' shares. Their forecasts range from $90.00 to $150.00. On average, they expect Varian Medical Systems' stock price to reach $125.25 in the next twelve months. This suggests that the stock has a possible downside of 5.4%. View analysts' price targets for Varian Medical Systems.

What are Wall Street analysts saying about Varian Medical Systems stock?

Here are some recent quotes from research analysts about Varian Medical Systems stock:
  • 1. According to Zacks Investment Research, "Varian continues to gain from its core Oncology Systems segment, which saw solid overseas growth, especially in EMEA and China. In fact, management foresees tremendous opportunities in China owing to the recent tariff exclusions. Gross orders surged in the quarter. Management is optimistic about the recently-closed acquisitions of CyberHeart, Cancer Treatment Services International, Endocare and Alicon. Expansion in gross margin is an added positive. Varian retained its outlook for fiscal 2020. On the flip side, the Proton Solutions unit was weak in the quarter. Moreover, Varian saw some softness in orders in Japan. Economic stagnation due to coronavirus outbreak has been another dampener. Reflective of these, the stock has underperformed the industry in a year’s time. Varian exited the fiscal first quarter on a weak note." (4/10/2020)
  • 2. Barrington Research analysts commented, "We strongly suspect that radiation that is delivered via the Ethos system will receive very high marks from both clinicians and patients alike. Ethos currently has its CE Mark while a 510(k) regulatory clearance in the U.S. is still pending." (9/23/2019)

Has Varian Medical Systems been receiving favorable news coverage?

Press coverage about VAR stock has been trending extremely negative recently, according to InfoTrie Sentiment. InfoTrie ranks the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Varian Medical Systems earned a media sentiment score of -4.4 on InfoTrie's scale. They also gave news articles about the medical equipment provider a news buzz of 5.0 out of 10, meaning that recent news coverage is somewhat likely to have an effect on the stock's share price in the immediate future. View the latest news aboutVarian Medical Systems.

Are investors shorting Varian Medical Systems?

Varian Medical Systems saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 3,020,000 shares, an increase of 21.8% from the April 15th total of 2,480,000 shares. Based on an average trading volume of 909,300 shares, the short-interest ratio is currently 3.3 days. Approximately 3.3% of the shares of the stock are short sold. View Varian Medical Systems' Current Options Chain.

Who are some of Varian Medical Systems' key competitors?

What other stocks do shareholders of Varian Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Varian Medical Systems investors own include NVIDIA (NVDA), Gilead Sciences (GILD), Netflix (NFLX), AT&T (T), Thermo Fisher Scientific (TMO), Visa (V), Align Technology (ALGN), Intel (INTC), Pfizer (PFE) and Verizon Communications (VZ).

Who are Varian Medical Systems' key executives?

Varian Medical Systems' management team includes the following people:
  • Mr. Dow R. Wilson, Pres, CEO & Director (Age 60)
  • Mr. Gary E. Bischoping Jr., Sr. VP of Fin. & CFO (Age 51)
  • Mr. John W. Kuo, Sr. VP, Gen. Counsel & Corp. Sec. (Age 56)
  • Ms. Kolleen T. Kennedy, Chief Growth Officer & Pres of Proton Solutions (Age 60)
  • Mr. Kevin O'Reilly, Sr. VP of Global Operations

What is Varian Medical Systems' stock symbol?

Varian Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "VAR."

Who are Varian Medical Systems' major shareholders?

Varian Medical Systems' stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (11.42%), State Street Corp (4.65%), Fiera Capital Corp (3.68%), Loomis Sayles & Co. L P (3.44%), Wells Fargo & Company MN (2.64%) and Wellington Management Group LLP (2.33%). Company insiders that own Varian Medical Systems stock include Christopher A Toth, Dow R Wilson, Gary E Bischoping Jr, John W Kuo, Kolleen T Kennedy, Magnus Momsen, R Andrew Eckert and Timothy E Guertin. View institutional ownership trends for Varian Medical Systems.

Which institutional investors are selling Varian Medical Systems stock?

VAR stock was sold by a variety of institutional investors in the last quarter, including AJO LP, Schroder Investment Management Group, Janus Henderson Group PLC, AQR Capital Management LLC, Smith Asset Management Group LP, Loomis Sayles & Co. L P, Alberta Investment Management Corp, and Pictet Asset Management Ltd.. Company insiders that have sold Varian Medical Systems company stock in the last year include Christopher A Toth, Dow R Wilson, Gary E Bischoping Jr, John W Kuo, Kolleen T Kennedy, Magnus Momsen, R Andrew Eckert, and Timothy E Guertin. View insider buying and selling activity for Varian Medical Systems.

Which institutional investors are buying Varian Medical Systems stock?

VAR stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Mackenzie Financial Corp, Viking Global Investors LP, DSM Capital Partners LLC, AXA, Frontier Capital Management Co. LLC, APG Asset Management N.V., and APG Asset Management N.V.. View insider buying and selling activity for Varian Medical Systems.

How do I buy shares of Varian Medical Systems?

Shares of VAR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Varian Medical Systems' stock price today?

One share of VAR stock can currently be purchased for approximately $132.37.

How big of a company is Varian Medical Systems?

Varian Medical Systems has a market capitalization of $12.02 billion and generates $3.23 billion in revenue each year. The medical equipment provider earns $291.90 million in net income (profit) each year or $4.63 on an earnings per share basis. Varian Medical Systems employs 10,062 workers across the globe.

What is Varian Medical Systems' official website?

The official website for Varian Medical Systems is www.varian.com.

How can I contact Varian Medical Systems?

Varian Medical Systems' mailing address is 3100 Hansen Way, Palo Alto CA, 94304. The medical equipment provider can be reached via phone at 650-493-4000 or via email at [email protected]

This page was last updated on 6/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.